In vivo effects of tumor necrosis factor-alpha or flavone acetic acid in combination with doxorubicin on multidrug-resistant B16 melanoma. [electronic resource]
- Anti-cancer drugs May 1996
- 281-7 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0959-4973
10.1097/00001813-199605000-00007 doi
Animals Antibiotics, Antineoplastic--administration & dosage Antineoplastic Combined Chemotherapy Protocols--therapeutic use Dose-Response Relationship, Drug Doxorubicin--administration & dosage Drug Resistance, Multiple Drug Resistance, Neoplasm Female Flavonoids--administration & dosage Melanoma, Experimental--drug therapy Mice Skin Neoplasms--drug therapy Tumor Necrosis Factor-alpha--administration & dosage